Safety and Efficacy Study of IVB102 Injection in Subjects With X-linked Retinoschisis

Clinical trial NCT06289452 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06289452
Sponsor: InnoVec Biotherapeutics Inc.
Status: ACTIVE_NOT_RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Retinoschisis Retinal Disease Retinal Degeneration Eye Diseases

Start date: 2024-03-08
Primary completion: 2025-12-31
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.